Zobrazeno 1 - 2
of 2
pro vyhledávání: '"O V Remeniak"'
Autor:
V V Kostjukov, Uwe Ritter, Yu. I. Prylutskyy, O V Remeniak, O.V. Lynchak, Svitlana Prylutska, Maxim P. Evstigneev, Volodymyr Rybalchenko, Peter Scharff
Publikováno v:
Experimental Oncology. :106-111
Background Cisplatin (Cis-Pt) is a widely used anticancer drug but its therapeutic efficiency is limited by hemato-, cardio-, hepato-, nephro- and neurotoxicity. Complexation of Cis-Pt with C60 fullerene nanoparticle will allow to enhance the antitum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13d18a73ec87f252167fc200985d02c0
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13030
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-2.13030
Autor:
S V, Prylutska, O V, Lynchak, V V, Kostjukov, M P, Evstigneev, O V, Remeniak, V K, Rybalchenko, Yu I, Prylutskyy, U, Ritter, P, Scharff
Publikováno v:
Experimental oncology. 41(2)
Cisplatin (Cis-Pt) is a widely used anticancer drug but its therapeutic efficiency is limited by hemato-, cardio-, hepato-, nephro- and neurotoxicity. Complexation of Cis-Pt with CTo estimate the antitumor effects of С60-Cis-Pt nanocomplex in Lewis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::548167cc46971b27ca9b556e36a3f3f7
https://pubmed.ncbi.nlm.nih.gov/31262160
https://pubmed.ncbi.nlm.nih.gov/31262160